Inflammation and cancer have been two of the most studied topics in Biomedical Sciences during the last decades. Scientific and technological advances in the fields of genomics and proteomics have made it is possible to establish with precision a great variety of immunological, cellular and genetic mechanisms that allow inflammation to be directly associated with cancer. Of the many studies derived from this topic, the one written by Hanahan and Weinberg in 2000 stands out, since it describes the biology of cancer in six proper characteristics or hallmarks of tumor development, which are nothing more than a series of responses and biological interactions of tumor cells in their initiation, development and progression phases, which are favored by elements directly or indirectly associated with inflammation. A decade later, the same authors have added more hallmarks to tumor biology and have dug into the role of the inflammatory response as a constant element that allows tumor development and invasion, since the inflammatory response is modulated and organized to promote key elements for tumor survival. The importance of the inflammatory infiltrate is key to understanding the development of neoplasms. This review will describe the main inflammatory cellular elements associated and modified by cancer cells to evade their elimination by the host, and some mechanisms to facilitate their progression.
Resúmen
La inflamación y el cáncer han sido dos de los temas más estudiados en las ciencias Médico Biológicas durante las últimas décadas. El avance científico y tecnológico en los campos de la genómica y proteómica ha permitido establecer con exactitud una gran variedad de mecanismos inmunológicos, celulares y genéticos que permiten asociar directamente la inflamación con él cáncer. De los múltiples estudios derivados de este tema, sobresale el escrito por Hanahan y Weinberg (2000), que describe la biología del cáncer en seis características propias o hallmarks del desarrollo tumoral, que no son más que una serie de respuestas e interacciones biológicas de las células tumorales en sus fases de inicio, desarrollo y progresión, favorecidas por elementos asociados directa o indirectamente con la inflamación. Una década después, los mismos investigadores han añadido más hallmarks a la biología tumoral y han ahondado en el papel que juega la respuesta inflamatoria como un elemento constante que facilita el desarrollo y la invasión de tumores, puesto que la respuesta inflamatoria está modulada y organizada para promover los elementos clave para la supervivencia tumoral. La importancia del infiltrado inflamatorio es clave para comprender el desarrollo de las neoplasias. Esta revisión describirá los principales elementos celulares inflamatorios relacionados y modificados por las células cancerosas para evadir su eliminación por parte del huésped y algunos mecanismos para facilitar su progresión.
Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sept | Oct | Nov | Dic |
---|---|---|---|---|---|---|---|---|---|---|---|
- | 10 | 28 | 18 | 17 | 4 | 10 | 16 | 10 | 13 | 11 | 3 |
Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sept | Oct | Nov | Dic |
---|---|---|---|---|---|---|---|---|---|---|---|
9 | 9 | 7 | 11 | 6 | 6 | 10 | 10 | 6 | 10 | 8 | 5 |
Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sept | Oct | Nov | Dic |
---|---|---|---|---|---|---|---|---|---|---|---|
11 | 12 | 15 | 9 | 6 | - | - | - | - | - | - | - |
Aggarwal, B., Shishodia, S., Sandur, S., Pandey, M. &
Sethi, G. (2006). Inflammation and cancer: how hot is
the link? Biochemical pharmacology, 72(11), 1605-
1621.
Alfaro, C., Sanmamed, M., Rodriguez-Ruiz, M., Teijeira,
Á., Oñate, C., González, Á., Ponz, M., Schalper, K., Pérez-
Gracia, J. & Melero, I. (2017). Interleukin-8 in cancer
pathogenesis, treatment and follow-up. Cancer
treatment reviews, 60, 24-31.
Allavena, P., Germano, G., Marchesi, F. & Mantovani, A.
(2011). Chemokines in cancer related inflammation.
Experimental cell research, 317(5), 664-673.
Balkwill, F., Capasso, M. & Hagemann, T. (2012). The
tumor microenvironment at a glance. Journal of Cell
Science, 125, 5591-5596.
Bertazza, L. & Mocellin, S. (2010). The dual role of tumor
necrosis factor (TNF) in cancer biology. Current
medicinal chemistry, 17(29), 3337-3352.
Burkholder, B., Huang, R., Burgess, R., Luo, S., Jones, V.,
Zhang, W., Lv, Z., Gao, C., Wang, B., Zhang, Y. & Huang,
R. (2014). Tumor-induced perturbations of cytokines
and immune cell networks. Biochimica et biophysica
acta, 1845(2), 182-201.
Butera, G., Pacchiana, R. & Donadelli, M. (2018). Autocrine
mechanisms of cancer chemoresistance. Seminars
in cell & developmental biology, 78, 3-12.
Chen, D. S. & Mellman, I. (2013). Oncology meets
immunology: the cancer-immunity cycle. Immunity,
39(1), 1-10.
Chen, D. S. & Mellman I. (2017). Elements of cáncer
immunity and the cancer-immune set point. Nature,
542, 321-330.
Defourny, S., Romanucci, M., Grieco, V., Quaglione,
G., Santolini, C. & Salda, L. D. (2019). TumorMicroenvironment
Interaction: Analysis of Mast Cell Populations
in Normal Tissue and Proliferative Disorders
of the Canine Prostate. Veterinary Sciences, 6, 16.
De Visser, K. D. & Jonkers, J. (2009). Towards understanding
the role of cancer-associated inflammation
in chemoresistance. Current pharmaceutical
design, 15(16), 1844-1853.
Diakos, C., Charles, K., McMillan, D. & Clarke, S. (2014).
Cancer-related inflammation and treatment eectiveness.
The Lancet. Oncology, 15(11), e493-503.
Duray, A., Demoulin, S., Hubert, P., Delvenne, P. &
Saussez, S. (2010). Immune Suppression in Head and
Neck Cancers: A Review. Clinical and Developmental
Immunology, 1-15. doi:10.1155/2010/701657
Fernandes, J. V., Cobucci, R., Jatobá, C. A., Fernandes,
T. A., Azevedo, J. W. & Araújo, J. M. (2015). The Role
of the Mediators of Inflammation in Cancer Development.
Pathology & Oncology Research, 21, 527-
534.
Germano, G., Allavena, P. & Mantovani, A. (2008).
Cytokines as a key component of cancer-related inflammation.
Cytokine, 43(3), 374-379.
Gonzalez, H., Hagerling, C. & Werb, Z. (2018). Roles
of the immune system in cancer: from tumor initiation
to metastatic progression. Genes & development,
32 (19-20), 1267-1284.
Greten, F. & Grivennikov, S. (2019). Inflammation
and Cancer: Triggers, Mechanisms, and Consequences.
Immunity, 51(1), 27-41.
Grivennikov, S. I., Greten, F. R. & Karin, M. (2010).
Immunity, Inflammation, and Cancer. Cell, 140(6),
883-899.
Hanahan, D. & Weinberg, R. (2011). Hallmarks of Cancer:
The Next Generation. Cell, 144, 646-674.
Huang, A., Cao, S., & Tang, L. (2017). The tumor microenvironment
and inflammatory breast cancer. Journal
of Cancer, 8, 1884-1891.
Jinushi, M. (2014). Role of cancer stem cell-associated
inflammation in creating pro-inflammatory tumorigenic
microenvironments. Oncoimmunology, 3.
Kalluri, R. & Weinberg, R. (2009). The basics of epithelial-
mesenchymal transition. The Journal of clinical
investigation, 119(6), 1420-1428.
Kim, J. & Bae, J. (2016). Tumor-Associated Macrophages
and Neutrophils in Tumor Microenvironment.
Mediators of Inflammation. https://doi.
org/10.1155/2016/6058147
Korniluk, A., Koper, O., Kemona, H. & Dymicka-
Piekarska, V. (2016). From inflammation to cancer.
Irish Journal of Medical Science, 186, 57-62.
Kumari, N., Dwarakanath, B., Das, A. & Bhatt, A. (2016).
Role of interleukin-6 in cancer progression and therapeutic
resistance. Tumor Biology, 37, 11553-11572.
Kundu, J. K. & Surh, Y. (2012). Emerging avenues linking
inflammation and cancer. Free radical biology &
medicine, 52(9), 2013-2037.
Landskron, G., Fuente, M. D., Thuwajit, P., Thuwajit,
C. & Hermoso, M. (2014). Chronic Inflammation
and Cytokines in the Tumor Microenvironment.
Journal of Immunology Research. https://doi.
org/10.1155/2014/149185
Lebrec, H., Ponce, R., Preston, B. D., Iles, J., Born, T. &
Hooper, M. (2015). Tumor necrosis factor, tumor necrosis
factor inhibition, and cancer risk. Current Medical
Research and Opinion, 31, 557-574.
Lingappan, K. (2018). NF-κB in Oxidative Stress. Current
opinion in toxicology, 7, 81-86.
Ortiz-Montero, P., Londoño-Vallejo, A. & Vernot, J.-P.
(2017). Senescence-associated IL-6 and IL-8 cytokines
induce a self- and cross-reinforced senescence/
inflammatory milieu strengthening tumorigenic capabilities
in the MCF-7 breast cancer cell line. Cell Communication
and Signaling, 15(1), 17.
Pesic, M. & Greten, F. R. (2016). Inflammation and cancer:
tissue regeneration gone awry. Current Opinion in
Cell Biology, 43, 55-61.
Porta, C., Larghi, P., Rimoldi, M., Grazia Totaro, M., Allavena,
P., Mantovani, A. & Sica, A. (2009). Cellular and
molecular pathways linking inflammation and cancer.
Immunobiology, 214(9-10), 761-777.
Raposo, T. P., Beirão, B. C. B., Pang, L. Y., Queiroga, F.
L., & Argyle, D. J. (2015). Inflammation and cancer:
Till death tears them apart. The Veterinary Journal,
205(2), 161-174.
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal,
B. B. (2010). Oxidative stress, inflammation, and cancer:
How are they linked? Free Radical Biology and
Medicine, 49(11), 1603-1616.
Shalapour, S. & Karin, M. (2015). Immunity, inflammation,
and cancer: an eternal fight between good
and evil. The Journal of clinical investigation, 125(9),
3347-55.
Taniguchi, K. & Karin, M. (2018). NF-κB, inflammation,
immunity and cancer: coming of age. Nature Reviews
Immunology, 18, 309-324.
Valavanidis, A., Vlachogianni, T. & Fiotakis, K. (2009).
Tobacco Smoke: Involvement of Reactive Oxygen
Species and Stable Free Radicals in Mechanisms of
Oxidative Damage, Carcinogenesis and Synergistic
Eects with Other Respirable Particles. International
Journal of Environmental Research and Public Health,
6, 445-462.
Valavanidis, A., Vlachogianni, T., Fiotakis, K. & Loridas,
S. (2013). Pulmonary Oxidative Stress, Inflammation
and Cancer: Respirable Particulate Matter, Fibrous
Dusts and Ozone as Major Causes of Lung Carcinogen-esis through Reactive Oxygen Species Mechanisms.
International Journal of Environmental Research and
Public Health, 10, 3886-3907.
Vinay, D., Ryan, E., Pawelec, G., Talib, W. H., Stagg, J.,
Elkord, E., Lichtor, T., Decker, W., Whelan, R., Kumara,
H. S., Signori, E., Honoki, K., Georgakilas, A., Amin, A.,
Helferich, W., Boosani, C., Guha, G., Ciriolo, M., Chen,
S. S., Mohammed, S., Azmi, A., Keith, W., Bilsland, A.,
Bhakta, D., Halicka, D., Fujii, H., Aquilano, K., Ashraf, S.,
Nowsheen, S., Yang, X., Choi, B.K. & Kwon, B. (2015).
Immune evasion in cancer: Mechanistic basis and
therapeutic strategies. Seminars in cancer biology,
35 Suppl, S185-S198.
Voulgari, A. & Pintzas, A. (2009). Epithelial-mesenchymal
transition in cancer metastasis: mechanisms markers and strategies to overcome drug resistance
in the clinic. Biochimica et biophysica acta, 1796(2),
75-90.
Waugh, D. & Wilson, C. (2008). The Interleukin-8 Pathway
in Cancer. Clinical Cancer Research, 14, 6735-
6741.
Yao, Z., Fenoglio, S., Gao, D., Camiolo, M., Stiles, B.,
Lindsted, T., Schlederer, M., Johns, C., Altorki, N., Mittal,
V., Kenner, L. & Sordella, R. (2010). TGF-β IL-6 axis
mediates selective and adaptive mechanisms of resistance
to molecular targeted therapy in lung cancer.
Proceedings of the National Academy of Sciences,
107, 15535-15540.